Merck Becomes Sole Testing Provider for FDA-Approved Gene Therapies of Genetix Biotherapeutics
Merck signs a 5-year deal as sole testing provider for Genetix Biotherapeutics’ gene therapies, delivering end-to-end testing to support safe, reliable commercialisation of advanced therapies.
Sickle Cell Disease | 08/05/2026 | By News Bureau
India Unveils its First Indigenous CRISPR-based Gene Therapy 'BIRSA 101' for Sickle Cell Disease
India has formally begun its decisive journey towards becoming a Sickle Cell Disease–free nation, with Union Minister of State for Science & Technology Dr. Jitendra Singh launching the country's first indigenous CRISPR-based gene therapy for the condition.
Sickle Cell Disease | 20/11/2025 | By Dineshwori | 673
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy